Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.
| Revenue (Most Recent Fiscal Year) | $8.25B |
| Net Income (Most Recent Fiscal Year) | $478.00M |
| PE Ratio (Current Year Earnings Estimate) | 14.13 |
| PE Ratio (Trailing 12 Months) | 14.35 |
| PEG Ratio (Long Term Growth Estimate) | 9.00 |
| Price to Sales Ratio (Trailing 12 Months) | 1.76 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.96 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 8.58 |
| Pre-Tax Margin (Trailing 12 Months) | 19.85% |
| Net Margin (Trailing 12 Months) | 18.13% |
| Return on Equity (Trailing 12 Months) | 28.01% |
| Return on Assets (Trailing 12 Months) | 7.17% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.50 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.14 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 1.03 |
| Inventory Turnover (Trailing 12 Months) | 4.02 |
| Book Value per Share (Most Recent Fiscal Quarter) | $17.13 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.50 |
| Earnings per Share (Most Recent Fiscal Year) | $6.70 |
| Diluted Earnings per Share (Trailing 12 Months) | $8.68 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 173.45M |
| Free Float | 173.36M |
| Market Capitalization | $14.79B |
| Average Volume (Last 20 Days) | 1.14M |
| Beta (Past 60 Months) | 0.26 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.05% |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |